Bioscience Today

08/03/2026

Inclusive clinical trials are increasingly recognised as essential to achieving equitable health outcomes. Kate Shaw, of InnovativeTrials, examines how broader representation in trial populations improves the validity and applicability of findings across diverse patient groups.

By reducing disparities and addressing under-represented populations, inclusive research practices can help ensure innovations benefit all communities.

🔗 Read more: https://www.biosciencetoday.co.uk/inclusive-clinical-trials-will-drive-better-health-outcomes-for-all/

07/03/2026

Precision oncology trials are poised to come into their own this year as targeted therapies, biomarker stratification and adaptive designs converge to improve outcomes, shares Dr Gen Li, CEO and Founder, Phesi.

This evolution in trial design could accelerate therapeutic breakthroughs and reshape cancer drug development.

👉 Explore the full feature: https://www.biosciencetoday.co.uk/in-2026-precision-oncology-trials-will-finally-come-into-their-own/

06/03/2026

Europa Biosite Acquires Stratech Scientific, Expanding Their Product Offering and Strengthening UK Customer Reach https://www.biosciencetoday.co.uk/europa-biosite-acquires-stratech-scientific-expanding-their-product-offering-and-strengthening-uk-customer-reach/

Europa Biosite, a leading pan-European life science distribution group, today announced the acquisition of Stratech Scientific Limited by its UK subsidiary, Cambridge Bioscience. Stratech Scientific is a well-respected and long-established UK life science distributor, known for its high-quality rese...

06/03/2026

A new study, led by UCL, links poorer heart health in middle age with increased dementia risk later in life, highlighting the long-term impact of cardiovascular health on brain function.

The research suggests that proactive cardiac care could be an important strategy in dementia prevention.

🔎 Read the study insights: https://www.biosciencetoday.co.uk/poorer-heart-health-in-middle-age-linked-to-increased-dementia-risk/

05/03/2026

In a clinical trial led by Stanford Medicine, a breakthrough eye prosthesis has restored vision in patients with previously untreatable blindness, marking significant progress in sensory neuroscience and bioengineering. The device interfaces directly with visual pathways to deliver meaningful visual perception.

🔎 Learn more: https://www.biosciencetoday.co.uk/eye-prosthesis-restores-sight/

04/03/2026

Intellectual property disputes remain a major challenge for life sciences organisations investing in innovation.

This feature from Bernhard Maier, partner and head of arbitration at Browne Jacobson LLP, explores how arbitration and alternative dispute resolution are increasingly used to settle complex IP conflicts without protracted litigation.

👉 Read the full article: https://www.biosciencetoday.co.uk/arbitrating-innovation-resolving-ip-disputes-in-life-sciences/

04/03/2026

Transduction-ready viral particles https://www.biosciencetoday.co.uk/transduction-ready-viral-particles/

Amsbio offers a comprehensive range of pre-made lentiviral particles for delivering target genes into most types of dividing and non-dividing mammalian cells in vitro and in vivo. Lentiviral particles provide long-term, stable expression of genes, making them ideal for stable cell line engineering,....

03/03/2026

New research using Flow Neuroscience’s medical device indicates that at-home brain stimulation can reduce relapse in major depression, offering promise for long-term mental health management. The study shows that regular, non-invasive neuromodulation may help sustain remission beyond traditional treatment windows.

🔗 Read more: https://www.biosciencetoday.co.uk/at-home-brain-stimulation-prevents-major-depression-relapse/

02/03/2026

A recent poll by The Pistoia Alliance found that 1 in 4 life sciences professionals are unaware of what data their AI models use, raising concerns about transparency, model bias and regulatory risk.

This insight highlights a growing need for clear governance frameworks and better education around data practices in AI applications.

🔎 Read the full story: https://www.biosciencetoday.co.uk/one-in-4-life-sciences-professionals-dont-know-what-data-their-ai-models-use/

01/03/2026

A new study by Université de Genève sheds light on the intricate mechanisms that ensure chromosomes separate accurately during cell division - a process fundamental to genetic stability.

Understanding these molecular safeguards is critical, as errors in chromosome segregation are linked to cancer and other serious conditions.

🔎 Explore the research: https://www.biosciencetoday.co.uk/how-chromosomes-separate-accurately/

28/02/2026

Researchers at University of Aberdeen have identified a potential new therapeutic target that could change how asthma is treated.

By uncovering previously underexplored biological pathways, the findings may support the development of more effective and targeted interventions for patients with chronic respiratory disease.

📖 Read the full story: https://www.biosciencetoday.co.uk/potential-new-therapeutic-target-for-asthma-discovered/